Mr. Davis joined Arrowhead in May 2023 and is presently Senior Vice President, Cardiovascular/Metabolic Franchise Head.

Mr. Davis has over 25 years of global experience in the biopharmaceutical industry.  Prior to joining Arrowhead, he was Vice President Global Marketing and Access Lead at Sobi, a biopharmaceutical company focused on rare disease.  Mr. Davis also held roles of increasing responsibility at Amgen Inc. where he was Global Marketing Lead and Global Product General Manager for Amgen’s leading growth franchise in the cardiovascular therapeutic area.

He has broad international experience in the U.S., E.U., South America, and Asia Pacific regions with multi-year assignments abroad in Switzerland, Australia, and South America.  Mr. Davis has deep experience commercializing launch, growth, and legacy brands across a variety of therapeutic categories.

He received his MBA from The Wharton School and his BA in Economics from Harvard University.

As a leader, I feel a strong responsibility to ensure our innovations reach those who need them most, enabling timely access to treatments. Each breakthrough brings new hope, and seeing its impact drives my passion to deliver real change where it matters.